• Neurocrine Biosciences EPS for the quarter ending December 31, 2024 was $1.00, a 32.89% decline year-over-year.
• Neurocrine Biosciences 2024 annual EPS was $3.29, a 33.2% increase from 2023.
• Neurocrine Biosciences 2023 annual EPS was $2.47, a 58.33% increase from 2022.
• Neurocrine Biosciences 2022 annual EPS was $1.56, a 69.57% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.